Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies

<b>(1) Background and Objectives:</b> Dark-blood late gadolinium enhancement has been shown to be a reliable cardiac magnetic resonance (CMR) method for assessing viability and depicting myocardial scarring in ischemic cardiomyopathy. The aim of this study was to evaluate dark-blood LGE...

Full description

Bibliographic Details
Main Authors: Jan M. Brendel, Robert J. Holtackers, Jan N. Geisel, Jens Kübler, Florian Hagen, Meinrad Gawaz, Konstantin Nikolaou, Simon Greulich, Patrick Krumm
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/9/1634
_version_ 1797602802990579712
author Jan M. Brendel
Robert J. Holtackers
Jan N. Geisel
Jens Kübler
Florian Hagen
Meinrad Gawaz
Konstantin Nikolaou
Simon Greulich
Patrick Krumm
author_facet Jan M. Brendel
Robert J. Holtackers
Jan N. Geisel
Jens Kübler
Florian Hagen
Meinrad Gawaz
Konstantin Nikolaou
Simon Greulich
Patrick Krumm
author_sort Jan M. Brendel
collection DOAJ
description <b>(1) Background and Objectives:</b> Dark-blood late gadolinium enhancement has been shown to be a reliable cardiac magnetic resonance (CMR) method for assessing viability and depicting myocardial scarring in ischemic cardiomyopathy. The aim of this study was to evaluate dark-blood LGE imaging compared with conventional bright-blood LGE for the detection of myocardial scarring in non-ischemic cardiomyopathies. <b>(2) Materials and Methods:</b> Patients with suspected non-ischemic cardiomyopathy were prospectively enrolled in this single-centre study from January 2020 to March 2023. All patients underwent 1.5 T CMR with both dark-blood and conventional bright-blood LGE imaging. Corresponding short-axis stacks of both techniques were analysed for the presence, distribution, pattern, and localisation of LGE, as well as the quantitative scar size (%). <b>(3) Results:</b> 343 patients (age 44 ± 17 years; 124 women) with suspected non-ischemic cardiomyopathy were examined. LGE was detected in 123 of 343 cases (36%) with excellent inter-reader agreement (κ 0.97–0.99) for both LGE techniques. Dark-blood LGE showed a sensitivity of 99% (CI 98–100), specificity of 99% (CI 98–100), and an accuracy of 99% (CI 99–100) for the detection of non-ischemic scarring. No significant difference in total scar size (%) was observed. Dark-blood imaging with mean 5.35 ± 4.32% enhanced volume of total myocardial volume, bright-blood with 5.24 ± 4.28%, <i>p</i> = 0.84. <b>(4) Conclusions:</b> Dark-blood LGE imaging is non-inferior to conventional bright-blood LGE imaging in detecting non-ischemic scarring. Therefore, dark-blood LGE imaging may become an equivalent method for the detection of both ischemic and non-ischemic scars.
first_indexed 2024-03-11T04:21:39Z
format Article
id doaj.art-e85e569df6a24fe685dc027d595d523c
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-11T04:21:39Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-e85e569df6a24fe685dc027d595d523c2023-11-17T22:46:22ZengMDPI AGDiagnostics2075-44182023-05-01139163410.3390/diagnostics13091634Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic CardiomyopathiesJan M. Brendel0Robert J. Holtackers1Jan N. Geisel2Jens Kübler3Florian Hagen4Meinrad Gawaz5Konstantin Nikolaou6Simon Greulich7Patrick Krumm8Department of Radiology, Diagnostic and Interventional Radiology, University of Tübingen Hoppe-Seyler-Straße 3, 72076 Tübingen, GermanyDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Centre, 6229 HX Maastricht, The NetherlandsDepartment of Radiology, Diagnostic and Interventional Radiology, University of Tübingen Hoppe-Seyler-Straße 3, 72076 Tübingen, GermanyDepartment of Radiology, Diagnostic and Interventional Radiology, University of Tübingen Hoppe-Seyler-Straße 3, 72076 Tübingen, GermanyDepartment of Radiology, Diagnostic and Interventional Radiology, University of Tübingen Hoppe-Seyler-Straße 3, 72076 Tübingen, GermanyDepartment of Internal Medicine III, Cardiology and Angiology, University of Tübingen Otfried-Müller-Straße 10, 72076 Tübingen, GermanyDepartment of Radiology, Diagnostic and Interventional Radiology, University of Tübingen Hoppe-Seyler-Straße 3, 72076 Tübingen, GermanyDepartment of Internal Medicine III, Cardiology and Angiology, University of Tübingen Otfried-Müller-Straße 10, 72076 Tübingen, GermanyDepartment of Radiology, Diagnostic and Interventional Radiology, University of Tübingen Hoppe-Seyler-Straße 3, 72076 Tübingen, Germany<b>(1) Background and Objectives:</b> Dark-blood late gadolinium enhancement has been shown to be a reliable cardiac magnetic resonance (CMR) method for assessing viability and depicting myocardial scarring in ischemic cardiomyopathy. The aim of this study was to evaluate dark-blood LGE imaging compared with conventional bright-blood LGE for the detection of myocardial scarring in non-ischemic cardiomyopathies. <b>(2) Materials and Methods:</b> Patients with suspected non-ischemic cardiomyopathy were prospectively enrolled in this single-centre study from January 2020 to March 2023. All patients underwent 1.5 T CMR with both dark-blood and conventional bright-blood LGE imaging. Corresponding short-axis stacks of both techniques were analysed for the presence, distribution, pattern, and localisation of LGE, as well as the quantitative scar size (%). <b>(3) Results:</b> 343 patients (age 44 ± 17 years; 124 women) with suspected non-ischemic cardiomyopathy were examined. LGE was detected in 123 of 343 cases (36%) with excellent inter-reader agreement (κ 0.97–0.99) for both LGE techniques. Dark-blood LGE showed a sensitivity of 99% (CI 98–100), specificity of 99% (CI 98–100), and an accuracy of 99% (CI 99–100) for the detection of non-ischemic scarring. No significant difference in total scar size (%) was observed. Dark-blood imaging with mean 5.35 ± 4.32% enhanced volume of total myocardial volume, bright-blood with 5.24 ± 4.28%, <i>p</i> = 0.84. <b>(4) Conclusions:</b> Dark-blood LGE imaging is non-inferior to conventional bright-blood LGE imaging in detecting non-ischemic scarring. Therefore, dark-blood LGE imaging may become an equivalent method for the detection of both ischemic and non-ischemic scars.https://www.mdpi.com/2075-4418/13/9/1634magnetic resonance imagingheartcontrast mediagadoliniumLGEcardiomyopathies
spellingShingle Jan M. Brendel
Robert J. Holtackers
Jan N. Geisel
Jens Kübler
Florian Hagen
Meinrad Gawaz
Konstantin Nikolaou
Simon Greulich
Patrick Krumm
Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
Diagnostics
magnetic resonance imaging
heart
contrast media
gadolinium
LGE
cardiomyopathies
title Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
title_full Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
title_fullStr Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
title_full_unstemmed Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
title_short Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
title_sort dark blood late gadolinium enhancement mri is noninferior to bright blood lge in non ischemic cardiomyopathies
topic magnetic resonance imaging
heart
contrast media
gadolinium
LGE
cardiomyopathies
url https://www.mdpi.com/2075-4418/13/9/1634
work_keys_str_mv AT janmbrendel darkbloodlategadoliniumenhancementmriisnoninferiortobrightbloodlgeinnonischemiccardiomyopathies
AT robertjholtackers darkbloodlategadoliniumenhancementmriisnoninferiortobrightbloodlgeinnonischemiccardiomyopathies
AT janngeisel darkbloodlategadoliniumenhancementmriisnoninferiortobrightbloodlgeinnonischemiccardiomyopathies
AT jenskubler darkbloodlategadoliniumenhancementmriisnoninferiortobrightbloodlgeinnonischemiccardiomyopathies
AT florianhagen darkbloodlategadoliniumenhancementmriisnoninferiortobrightbloodlgeinnonischemiccardiomyopathies
AT meinradgawaz darkbloodlategadoliniumenhancementmriisnoninferiortobrightbloodlgeinnonischemiccardiomyopathies
AT konstantinnikolaou darkbloodlategadoliniumenhancementmriisnoninferiortobrightbloodlgeinnonischemiccardiomyopathies
AT simongreulich darkbloodlategadoliniumenhancementmriisnoninferiortobrightbloodlgeinnonischemiccardiomyopathies
AT patrickkrumm darkbloodlategadoliniumenhancementmriisnoninferiortobrightbloodlgeinnonischemiccardiomyopathies